Dr. Prins’s research group studies immune-based therapies for the treatment of central nervous system (CNS) tumors. Currently, patients presenting with such malignancies are left with few treatment options. His research group is attempting to apply what we learn from pre-clinical models towards the implementation of immunotherapy clinical trials for brain tumor patients. Our work is currently involved in the following pre-clinical and clinical studies.
Read my PubMed publications